ACN 163 765 991
Prospectus for Initial Public Offering
The prospectus accessible on this page (Prospectus) contains an offer (Offer) of fully paid ordinary shares (Shares) in the capital of Exopharm Limited (ACN 163 765 991) (Company). The Prospectus is dated 6th November 2018 and will expire 13 months from this date.
You must read this important notice before you attempt to access the electronic version of the Prospectus through this website. The information on this page does not form part of the Prospectus. If you do not understand it, you should consult your professional adviser without delay.
By accessing the Prospectus, you acknowledge that you have read and accepted the terms set out in this notice. Please indicate your agreement or otherwise at the bottom of this notice.
Lodgement of Prospectus with ASIC
The paper form of the electronic version of the Prospectus accessible through this website has been lodged with the Australian Securities & Investments Commission (ASIC). Neither ASIC nor the Australian Securities Exchange (ASX) takes any responsibility for the contents of the Prospectus or the investment to which it relates.
The Company will apply to ASX within 7 days after the date of the Prospectus for admission of the Company to the official list of ASX and for quotation of the Shares (apart from any Shares that may be designated by ASX as “restricted securities”).
An offer of securities is not made on the basis of the electronic version of the Prospectus accessible through this website.
No Public Offer
No general public offer of Shares will be made under the Offer or the Prospectus. Members of the public wishing to apply for Shares under the Offer must do so through the lead manager to the Offer or a participating broker.
If you have received an invitation to participate in the offer of Shares made pursuant to the Prospectus from the lead manager or a participating broker and you wish to apply for Shares under the Offer, you should contact the lead manager or participating broker for information about how to submit your application.
Nothing contained on this website or in the Prospectus constitutes investment, legal, business, tax or other advice. In particular, the information on this website and in the Prospectus does not take into account your investment objectives, financial situation or particular needs. In making an investment decision, you must rely on your own examination of the Company, the Shares and terms of the offering, including the merits and risks involved. You should consult your professional advisers for investment, financial, legal, business or tax advice, as required.
For legal reasons, the electronic version of the Prospectus accessible through this website is available to persons accessing this website from within Australia only. If you are accessing this website from anywhere outside Australia, please do not download the electronic version of the Prospectus.
No action has been taken to register or qualify the Shares or the Offer or otherwise to permit a public offering of Shares in any jurisdiction outside Australia.
The Prospectus does not constitute an offer of Shares in any jurisdiction where, or to any person to whom, it would not be lawful to issue the Prospectus or make the Offer.
It is the responsibility of any applicant outside Australia to ensure compliance with all laws of any country relevant to their application, and any such applicant should consult their professional advisers as to whether any government or other consents are required, or whether any formalities need to be observed to enable them to apply for and be allotted any Shares.
The distribution of the Prospectus (including in electronic form) in jurisdictions outside Australia may be restricted by law and therefore persons outside Australia who obtain the Prospectus should seek advice on, and observe, any such restrictions.
Any failure to comply with these restrictions may constitute a violation of applicable securities laws. The Prospectus does not constitute an offer or invitation in any jurisdiction in which, or to any person to whom, it would be unlawful to make such an offer or invitation.
The Corporations Act 2001 (Cth) (Corporations Act) prohibits the Company from processing applications for Shares under the Prospectus in the 7 day period after the date of the Prospectus (Exposure Period). This period may be extended by ASIC for a further period of up to 7 days.
The purpose of the Exposure Period is to enable the Prospectus to be examined by ASIC and market participants prior to the raising of funds under the Offer. The examination may result in the identification of deficiencies in the Prospectus, in which case any application may need to be dealt with in accordance with section 724 of the Corporations Act.
Applications received during the Exposure Period will not be processed until after the expiry of the Exposure Period.
No preference will be conferred on any applications received during the Exposure Period.
By proceeding, you acknowledge and agree to the above statements.